Dr. Yair Schindel
When VC aMoon was established in 2017, “the premise was to invest heavily in the convergence of technology and biology, healthcare and data,” says Dr. Yair Schindel, its Managing Partner. Schindel and Marius Nacht, the other founder of the Israeli venture capital firm which has raised to date more than $1 billion, were talking to potential investors about “the coming tsunami of healthtech” over the next 10 years. “Now we see things happening that we only expected to see three or five years from now,” says Schindel. “In that sense, Covid put everything on steroids.”
Read more here
At the 
To respond effectively to a global pandemic, governments need to have access to very large volumes of healthcare data, collected over a long period of time with patient privacy protected, and sourced from many locations and populations around the world.
Herzliya, Israel-based 
Jerusalem-based 
Recent surveys, studies, forecasts and other quantitative assessments of AI highlight the number of manufacturing jobs eliminated by robots; why robots could replace financial analysts; the very small number of organizations not evaluating or using AI today; and the debate over the usefulness of Covid-19 contact-tracing.
“It is impossible to defeat an enemy that we cannot see,” 
News from Israel today about rapid progress in developing a COVID-19 vaccine and in identifying people at the highest risk of severe COVID-19 complications.
Recent surveys, studies, forecasts and other quantitative assessments of AI highlight the role AI plays in fighting the Coronavirus, the business impact of AI, and what the American public feels about it.